Bosutinib (SKI-606)

Name: Bosutinib (SKI-606)
Brand: Selleck Chemicals
SKU: S1014
Rating: 5 (98 reviews)

For research use only.

Licensed by Pfizer Catalog No.S1014

98 publications

CAS No. 380843-75-4

Bosutinib (SKI-606) is a novel, dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM in cell-free assays, respectively. Bosutinib also effectively decreases the activity of PI3K/AKT/mTOR, MAPK/ERK and JAK/STAT3 signaling pathways by blocking the phosphorylation levels of p-ERK, p-S6, and p-STAT3. Bosutinib promotes autophagy.

Selleck's Bosutinib (SKI-606) has been cited by 98 publications

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Nat Med, 2018, 24(2):232-238

PubMed: 29309057 ( click the link to review the publication )

Cancer Discov, 2016, 6(7):727-39

PubMed: 27231123 ( click the link to review the publication )

Br J Anaesth, 2021, S0007-0912(21)00090-8

PubMed: 33685634 ( click the link to review the publication )

EBioMedicine, 2021, 69:103457

PubMed: 34224975 ( click the link to review the publication )

Cell Chem Biol, 2021, S2451-9456(21)00303-2

PubMed: 34216546 ( click the link to review the publication )

Drug Metab Dispos, 2021, 49(1):53-61

PubMed: 33148688 ( click the link to review the publication )

Phytother Res, 2021, 10.1002/ptr.7089

PubMed: 33792976 ( click the link to review the publication )

Arch Virol, 2021, 166(5):1433-1438

PubMed: 33683474 ( click the link to review the publication )

Mol Cell, 2020, 80(6):1104-1122.e9

PubMed: 33259812 ( click the link to review the publication )

Nat Protoc, 2020, 15(2):421-449

PubMed: 31932771 ( click the link to review the publication )

Nat Commun, 2020, 11(1):5842

PubMed: 33203880 ( click the link to review the publication )

Nat Commun, 2020, 11(1):5704

PubMed: 33177525 ( click the link to review the publication )

Nat Commun, 2020, 29;11(1):2086

PubMed: 32350249 ( click the link to review the publication )

Genome Med, 2020, 18;12(1):17

PubMed: 32070411 ( click the link to review the publication )

Gut Microbes, 2020, 12(1):1-20

PubMed: 33006494 ( click the link to review the publication )

Cancers (Basel), 2020, 27;12(5)pii: E1087

PubMed: 32349331 ( click the link to review the publication )

Cancers (Basel), 2020, 13;12(2) pii: E436

PubMed: 32069833 ( click the link to review the publication )

PLoS Pathog, 2020, 16;16(3):e1008341

PubMed: 32176725 ( click the link to review the publication )

Cell Death Dis, 2020, 11(10):831

PubMed: 33024087 ( click the link to review the publication )

FASEB J, 2020, 34(3):3773-3791

PubMed: 31945226 ( click the link to review the publication )

Aging (Albany NY), 2020, 7;12(9):8221-8240

PubMed: 32379705 ( click the link to review the publication )

J Cell Sci, 2020, 14;133(9) pii: jcs240077

PubMed: 32198280 ( click the link to review the publication )
Int J Mol Sci, 2020, 21(23)E9276

PubMed: 33291786 ( click the link to review the publication )

Cancer Cell Int, 2020, 19;20:58

PubMed: 32099531 ( click the link to review the publication )

J Tissue Eng Regen Med, 2020, 14(4):575-587

PubMed: 32061178 ( click the link to review the publication )

Oncol Rep, 2020, 44(6):2581-2594

PubMed: 33125153 ( click the link to review the publication )

Hum Cell, 2020, 10.1007/s13577-020-00420-z

PubMed: 32870449 ( click the link to review the publication )

Hum Cell, 2020, 10.1007/s13577-020-00425-8

PubMed: 32886306 ( click the link to review the publication )

Exp Neurol, 2020, 328:113272

PubMed: 32142802 ( click the link to review the publication )

Blood Adv, 2020, 4(24):6106-6116

PubMed: 33351104 ( click the link to review the publication )

FEBS Lett, 2020, 10.1002/1873-3468.14008

PubMed: 33249578 ( click the link to review the publication )

J Immunother Cancer, 2020, 8(1):e000285

PubMed: 32581055 ( click the link to review the publication )

Nat Cell Biol, 2019, 21(6):778-790

PubMed: 31160710 ( click the link to review the publication )

J Clin Invest, 2019, 129(3):1167-1179

PubMed: 30629551 ( click the link to review the publication )

Haematologica, 2019, 10.3324/haematol.2019.215939

PubMed: 31289206 ( click the link to review the publication )

J Cell Biol, 2019, 218(9):3060-3076

PubMed: 31308216 ( click the link to review the publication )

Cancers (Basel), 2019, 11(6)

PubMed: 31181609 ( click the link to review the publication )

J Physiol, 2019, 597(6):1627-1642

PubMed: 30488437 ( click the link to review the publication )

Front Oncol, 2019, 9:586

PubMed: 31428570 ( click the link to review the publication )

Sci Rep, 2019, 9(1):5309

PubMed: 30926929 ( click the link to review the publication )

Mol Carcinog, 2019, 10.1002/mc.23139

PubMed: 31777985 ( click the link to review the publication )

Molecules, 2019, 24(3)

PubMed: 30754629 ( click the link to review the publication )

Leuk Lymphoma, 2019, 60(1):189-199

PubMed: 29741440 ( click the link to review the publication )

Exp Hematol, 2019, 77:36-40.e2

PubMed: 31493432 ( click the link to review the publication )

BMC Complement Altern Med, 2019, 19(1):105

PubMed: 31113420 ( click the link to review the publication )

Drugs R D, 2019, 19(2):149-166

PubMed: 30919310 ( click the link to review the publication )
Oncotarget, 2019, 10(23):2237-2251

PubMed: 31040916 ( click the link to review the publication )

Leuk Res, 2019, 78:36-44

PubMed: 30711891 ( click the link to review the publication )

Anat Rec (Hoboken), 2019, 302(12):2193-2200

PubMed: 31569304 ( click the link to review the publication )

Cancer Res, 2018, 78(22):6497-6508

PubMed: 30262461 ( click the link to review the publication )

Cancers (Basel), 2018, 10(12)

PubMed: 30572654 ( click the link to review the publication )

Pigment Cell Melanoma Res, 2018, 31(2):253-266

PubMed: 28972303 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(12):2622-2632

PubMed: 30282811 ( click the link to review the publication )

Mol Biol Cell, 2018, 10.1091/mbc.E18-08-0496

PubMed: 30303751 ( click the link to review the publication )

Biochem Pharmacol, 2018, 156:248-264

PubMed: 30142322 ( click the link to review the publication )

Int J Mol Sci, 2018,

PubMed: 29933569 ( click the link to review the publication )

Int J Oncol, 2018, 53(4):1544-1556

PubMed: 30066854 ( click the link to review the publication )

Transl Oncol, 2018, 11(6):1406-1418

PubMed: 30219696 ( click the link to review the publication )

Onco Targets Ther, 2018,

PubMed: 29695913 ( click the link to review the publication )

J Neurol Sci, 2018, 391:90-99

PubMed: 30103978 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 502(1):110-115

PubMed: 29787755 ( click the link to review the publication )

Nat Commun, 2017, 1;8(1):1232

PubMed: 29089541 ( click the link to review the publication )

Elife, 2017, 6

PubMed: 28199182 ( click the link to review the publication )

Arch Toxicol, 2017, 91(8):2921-2938

PubMed: 28032146 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(11):2563-2571

PubMed: 28839001 ( click the link to review the publication )

Mol Cancer Ther, 2017, pii: molcanther.0669

PubMed: 28223426 ( click the link to review the publication )

Mol Cancer Ther, 2017, 16(9):1989-1998

PubMed: 28637715 ( click the link to review the publication )

Transl Lung Cancer Res, 2017, 6(5):600-610

PubMed: 29114475 ( click the link to review the publication )

Biochim Biophys Acta, 2017, 1864(2):440-448

PubMed: 27913209 ( click the link to review the publication )

Oncotarget, 2017, 8(8):13832-13845

PubMed: 28099155 ( click the link to review the publication )
Cell Host Microbe, 2017, 21(6):754-768

PubMed: 28618271 ( click the link to review the publication )

Cancer Res, 2016, 76(23):6937-6949

PubMed: 27758892 ( click the link to review the publication )

Mol Cancer Ther, 2016, 10.1158/1535-7163

PubMed: 27196758 ( click the link to review the publication )

J Neurochem, 2016, 139(4):610-623

PubMed: 27507246 ( click the link to review the publication )

Int J Oncol, 2016, 49(1):402-10

PubMed: 27120977 ( click the link to review the publication )

Hum Mol Genet, 2015, 24(15):4296-305

PubMed: 25948553 ( click the link to review the publication )

Biochem J, 2015, 465(2):271-9

PubMed: 25351958 ( click the link to review the publication )

BMC Genomics, 2015, 16 Suppl 12:S2

PubMed: 26681397 ( click the link to review the publication )

Neuroscience, 2015, 304:316-27

PubMed: 26235435 ( click the link to review the publication )

Neurotox Res, 2015, 27(4):384-98

PubMed: 25782580 ( click the link to review the publication )

Oncotarget, 2015,

PubMed: 26325669 ( click the link to review the publication )

Drug Metab Dispos, 2014, 42(11):1851-7

PubMed: 25165131 ( click the link to review the publication )

Mol Hum Reprod, 2014, 10.1093/molehr/gau073

PubMed: 25180269 ( click the link to review the publication )

PLoS One, 2014, 9(1):e87014

PubMed: 24466315 ( click the link to review the publication )

PLoS One, 2014, 9(10):e111534

PubMed: 25356636 ( click the link to review the publication )

Pharmacogenet Genomics, 2014, 24(1):52-61

PubMed: 24322003 ( click the link to review the publication )

Anticancer Res, 2014, 34(4):1629-35

PubMed: 24692691 ( click the link to review the publication )

Blood, 2013, 122(7):1203-13

PubMed: 23836556 ( click the link to review the publication )

Mol Hum Reprod, 2013, 19(9):570-80

PubMed: 23630234 ( click the link to review the publication )

Pharmgenomics Pers Med, 2013, 6:63-72

PubMed: 24019750 ( click the link to review the publication )

Cancer Res, 2012, 72(5):1229-38

PubMed: 22241084 ( click the link to review the publication )

Mol Cell Biol, 2012, 32(2):320-32

PubMed: 22037769 ( click the link to review the publication )

Blood, 2011, 118(7):1885-98

PubMed: 21680801 ( click the link to review the publication )

Cancer Res, 2010, 70(19):7489-99

PubMed: 20709760 ( click the link to review the publication )
J Virol, 2010, 85(5):2296-303

PubMed: 21177802 ( click the link to review the publication )

J Biol Chem, 2010, 285(11):7977-85

PubMed: 20068039 ( click the link to review the publication )

Purity & Quality Control

Choose Selective Src Inhibitors

Biological Activity

Description

Targets

S6 kinase ^[7] ()	ERK ^[7] ()	STAT3 ^[7] ()	Abl ^[2] (Cell-free assay)	Src ^[1] (Cell-free assay)
			1 nM	1.2 nM

In vitro

Bosutinib is selective for Src over non-Src family kinases with an IC50 of 1.2 nM, and potently inhibits Src-dependent cell proliferation with an IC50 of 100 nM. ^[1] Bosutinib significantly inhibits the proliferation of Bcr-Abl-positive leukemia cell lines KU812, K562, and MEG-01 but not Molt-4, HL-60, Ramos, and other leukemia cell lines, with IC50 of 5 nM, 20 nM and 20 nM, respectively, more potently than that of STI-571. Similar to STI-571, Bosutinib displays antiproliferative activity against the Abl-MLV-transformed fibroblasts with IC50 of 90 nM. Bosutinib ablates tyrosine phosphorylation of Bcr-Abl and STAT5 in CML cells and of v-Abl expressed in fibroblasts at the concentration of ~50 nM, 10-25 nM and 200 nM, respectively, leading to the Bcr-Abl downstream signaling inhibition of Lyn/Hck phosphorylation. ^[2] Although unable to inhibit the proliferation and survival of breast cancer cells, Bosutinib significantly decreases the motility and invasion of breast cancer cells with IC50 of ~250 nM, involved with an increase in cell-to-cell adhesion and membrane localization of β-catenin. ^[3]

Cell Data

Cell Lines	Assay Type	Incubation Time	Activity Description	PMID
NB7	NXTDOWFWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVnHbo5IUUN3ME2wMlA5OjNzIDFOwG0>	NGnnVJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SW756	NIn6dI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHX0ZppKSzVyPUCuNVQxOjRiIN88US=>	NVSze2I5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
CTV-1	NU\0SI1ET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVTJR\|UxRTBwMU[zPVghKM7:TR?=	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HSC-4	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYHJR\|UxRTBwMUexOVghKM7:TR?=	NWnDW2tbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LAMA-84	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NFHUb\|FKSzVyPUCuNlg3PjRiIN88US=>	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KU812	MlHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mk\RTWM2OD1yLkO0NFY5KCEQvF2=	NXi1e\|hLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HCC1806	M{nDTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MYXJR\|UxRTBwM{WyNVYhKM7:TR?=	NVv1bJY6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
DOK	NX3YNFJiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M1jHOmlEPTB;MD6zO\|c5PiBizszN	NVrROI5HRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H209	Mom4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MljoTWM2OD1yLkSwPFA5KCEQvF2=	MoDvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EoL-1-cell	NF3RVYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NH7W[nVKSzVyPUCuOFE2PzZiIN88US=>	MljJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
H9	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2r3NWlEPTB;MD60N\|Q3PCBizszN	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
EM-2	NXTsTFhVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NEf1VohKSzVyPUCuOFM5QSBizszN	NYTFcnZERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H292	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnHJTWM2OD1yLkS0NVA5KCEQvF2=	M1m3e\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
697	NWP4TnJYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NX\DOJl[UUN3ME2wMlQ2PjN\|IDFOwG0>	MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BHT-101	NEDRWFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYPkTnJkUUN3ME2wMlQ3PTliIN88US=>	M37V[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
BE-13	MorCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlLsTWM2OD1yLkS4OVczKCEQvF2=	NHPZW2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
RS4-11	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmOxTWM2OD1yLkS4OVg1KCEQvF2=	Ml\jQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
IGROV-1	NFfyfpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NF73VXlKSzVyPUCuOFg4QTdiIN88US=>	M33ZOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KE-37	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXrJR\|UxRTBwNEm1NFkhKM7:TR?=	NFTiflQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
BV-173	NIDkUG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVTJR\|UxRTBwNUC3PVIhKM7:TR?=	M3HEflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MEG-01	MmXDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NX\0NnhqUUN3ME2wMlUyOjF2IDFOwG0>	NWfNbW4yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LB2241-RCC	NE\MS3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NH3PZ4RKSzVyPUCuOVM4OThiIN88US=>	Ml7aQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ACHN	M3n2[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MYnJR\|UxRTBwNUSwOlkhKM7:TR?=	M1u5TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CTB-1	NFnsWnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{DGfGlEPTB;MD61OFgzKCEQvF2=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HT-1080	NIjGN4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnPBTWM2OD1yLkW1N\|Q6KCEQvF2=	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
CHL-1	MmLJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFzVUFJKSzVyPUCuOVU1PjViIN88US=>	M{[5PFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EW-3	NUTBVGd{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFfUZYlKSzVyPUCuOVU6OzViIN88US=>	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ES1	NXX0ZZNxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{jYPWlEPTB;MD62O\|Q6QCBizszN	M4Tn[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KASUMI-1	MonpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MmfoTWM2OD1yLkeyN\|MhKM7:TR?=	M17WWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SW13	NIruTnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUTCTVhjUUN3ME2wMlc{Pzl6IDFOwG0>	MmLmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
A3-KAW	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4WxTGlEPTB;MD63PVIxQCBizszN	MmT2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
LB771-HNC	NXf0WZlDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NEXRSJhKSzVyPUCuPFMyODRiIN88US=>	M17OdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
OC-314	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3jv[GlEPTB;MD64Olk3PSBizszN	MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MLMA	NHf2[YJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYfJR\|UxRTBwOUC2O\|UhKM7:TR?=	NYftUHB2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KARPAS-45	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUHJR\|UxRTBwOUK0OlYhKM7:TR?=	M2Wxb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
CAL-27	M4PuOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NWLmNpN1UUN3ME2wMlkzQTB4IDFOwG0>	MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-NEP-1	NFjWdoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGTIVHRKSzVyPUCuPVczPDhiIN88US=>	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
COR-L105	M3KzdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1r4emlEPTB;MT6wNFM6PCBizszN	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
TI-73	M2Sy[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M365VmlEPTB;MT6wNVY2KCEQvF2=	NHT1d4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
JVM-3	MlS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MmXRTWM2OD1zLkC1NFE4KCEQvF2=	MojIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HAL-01	NIrhVm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYi3S4dqUUN3ME2xMlA5QDFiIN88US=>	MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
QIMR-WIL	NGjaOJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVPJR\|UxRTFwMEmwOVghKM7:TR?=	NXL6bndLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HSC-3	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYnXdZpUUUN3ME2xMlEyPzh\|IDFOwG0>	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KY821	MkHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHmw[2RKSzVyPUGuNVM{PTFiIN88US=>	MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
5637	MkjuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4K0UGlEPTB;MT6xN\|gxOyBizszN	Mk\0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
CAL-33	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWfVcoVxUUN3ME2xMlE6OzB{IDFOwG0>	MkL6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ES4	MkXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NYjKTmxwUUN3ME2xMlIxPzliIN88US=>	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BHY	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1u3XGlEPTB;MT6yNlg6OiBizszN	NX;PXXVxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LB1047-RCC	NIm5fWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Moe4TWM2OD1zLkKzO\|g2KCEQvF2=	NYPwOHBPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
H4	NIPCXYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NH7sVIlKSzVyPUGuNlQzPTViIN88US=>	NXPTTGExRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
RPMI-8866	NV\CTWR1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MnXYTWM2OD1zLkK2NVA3KCEQvF2=	NIfhRVU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HO-1-N-1	NXzzXnh6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3rlOmlEPTB;MT6yOlM3QSBizszN	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BB30-HNC	NFXydIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3Tib2lEPTB;MT6yPFcyPCBizszN	NV;yR4U2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
PC-14	NFTiVmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFXpUVJKSzVyPUGuNlkzODViIN88US=>	M{D4fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NUGC-3	NWPGc5RnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NX\FWVFKUUN3ME2xMlI6OzV4IDFOwG0>	NVO1W2pURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
A4-Fuk	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3rISWlEPTB;MT6zNFcxPCBizszN	MojqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MHH-NB-11	NEj5UGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NETUflJKSzVyPUGuN\|E{QDNiIN88US=>	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KOSC-2	M3;Gdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXrrcZhuUUN3ME2xMlMyPzd3IDFOwG0>	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A498	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVjJR\|UxRTFwNECxNVMhKM7:TR?=	M1vXbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KG-1	NWnjdJVST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Mn;XTWM2OD1zLkSxNlc{KCEQvF2=	NGLINYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
DEL	NU\tUZFpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MmTQTWM2OD1zLkSzOlU4KCEQvF2=	MkfnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EW-16	NWDLVVRtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVfJR\|UxRTFwNEO5O\|MhKM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BPH-1	NVj5PWNCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUjJR\|UxRTFwNES4NFUhKM7:TR?=	NXLkRpo1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
JAR	MmnrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFXGU4RKSzVyPUGuOFk{PiBizszN	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
J-RT3-T3-5	MkmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYPJR\|UxRTFwNUG3NlIhKM7:TR?=	M4SwPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
A375	NI\JWGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYXJR\|UxRTFwNUG3O\|IhKM7:TR?=	NWrvNWN[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SW954	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MkfUTWM2OD1zLkW1NFA4KCEQvF2=	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
Ca9-22	NWjSN5hnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVnJR\|UxRTFwNU[yOkAh\|ryP	NEHucFE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
D-566MG	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NGqxbodKSzVyPUGuOVcyPTViIN88US=>	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SCC-15	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NETiPGRKSzVyPUGuOlE5ODRiIN88US=>	Mnz5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HD-MY-Z	M2XzeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MlHGTWM2OD1zLk[zOVg1KCEQvF2=	NWrsOWRvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HT-1376	M2nudWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NUjkOY51UUN3ME2xMlY1OzZiIN88US=>	NGDOeWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
CAL-54	M1XnUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NF;WTIJKSzVyPUGuOlU4ODliIN88US=>	MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ONS-76	NV33SXFRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MniwTWM2OD1zLk[3OVUyKCEQvF2=	M3uzUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EFO-27	NFG0boRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUjIb4NzUUN3ME2xMlY5QTJiIN88US=>	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
769-P	NIrTfldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Ml7YTWM2OD1zLk[5OVk3KCEQvF2=	NXjoSopIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MV-4-11	MkfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NYPqPJRGUUN3ME2xMlY6QDV4IDFOwG0>	MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NKM-1	NGDnU3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXPJR\|UxRTFwN{G4NFIhKM7:TR?=	M2S5e\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
LOXIMVI	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXvJR\|UxRTFwN{S1PVkhKM7:TR?=	M4fCdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KYSE-140	NXP4UINMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NITUeXVKSzVyPUGuO\|U3PTViIN88US=>	M3:zRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ES5	M3;UdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NITMSWxKSzVyPUGuPFY4PDdiIN88US=>	M13tc\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
BB65-RCC	NYPEZYNHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Ml;pTWM2OD1zLki5PFQ6KCEQvF2=	NF\mWW89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HN	NVv3[2V3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHy3cpVKSzVyPUGuPFk5PzRiIN88US=>	NEDPVmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A101D	NH65emVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVrJR\|UxRTFwOUO2NlghKM7:TR?=	M1XJdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
LoVo	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVmzNJdRUUN3ME2xMlk4Pjd7IDFOwG0>	MlnXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H526	NUfWdnVTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYPEXYxxUUN3ME2xMlk6OzJ3IDFOwG0>	Mn;OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1693	NHXieIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4P2[mlEPTB;MT65PVg5QCBizszN	M3XR[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
OVCAR-4	NFT0WIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Mn;TTWM2OD1{LkCwOFM2KCEQvF2=	MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-HEP-1	NYLPWpJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M2XQV2lEPTB;Mj6wNFc1PSBizszN	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
C2BBe1	Mn6xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MXHJR\|UxRTJwMEOzO\|IhKM7:TR?=	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MEL-JUSO	NU[0OGZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVfJR\|UxRTJwMES0OlQhKM7:TR?=	NF3yd4o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MOLT-16	MoDOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1TzPGlEPTB;Mj6wO\|A2QCBizszN	NVra[HNJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NBsusSR	NH3tNnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXnJR\|UxRTJwMEm4PFkhKM7:TR?=	NV7SeXZ5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TK10	NW[1dZZrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXLJR\|UxRTJwMUO0OVghKM7:TR?=	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
CAL-39	NVHQR3lKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MmLVTWM2OD1{LkG0OFghKM7:TR?=	M1ntRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H2030	NILUSJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYfJR\|UxRTJwMUi5O\|MhKM7:TR?=	M3LBUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HCT-116	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3XKVGlEPTB;Mj6yNlk5PCBizszN	MnTYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HTC-C3	M2PpV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1jzSWlEPTB;Mj6yOlgzPCBizszN	MmHrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
TYK-nu	Ml;aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVzpfINQUUN3ME2yMlMxQTB7IDFOwG0>	NFe4dnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
FADU	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4DCemlEPTB;Mj6zNlI6PiBizszN	MmP2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
A431	M4Phemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NH3WW5ZKSzVyPUKuN\|cxOjViIN88US=>	NV\IN2VmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TE-11	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{D4eWlEPTB;Mj6zPFAyQSBizszN	MoewQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
CAL-12T	M{PITmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVzJR\|UxRTJwNEC0NVchKM7:TR?=	NGDWTpk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
DB	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MWfJR\|UxRTJwNEK4OlkhKM7:TR?=	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
L-363	NVvDNFlET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Mkj5TWM2OD1{LkSzOVA4KCEQvF2=	Mo[4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MSTO-211H	M{PaNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NYXhWmVPUUN3ME2yMlY3OzlzIDFOwG0>	Ml:wQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-UT-1	NEHB[FlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4jacGlEPTB;Mj63NVQxPiBizszN	NXzvXnhLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
RPMI-8226	Mme5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NE\vV4JKSzVyPUKuO\|MyPjRiIN88US=>	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SF295	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NF7lcHpKSzVyPUKuO\|Q{OSBizszN	NHzncVQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
OS-RC-2	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVzJR\|UxRTJwN{[2O\|MhKM7:TR?=	NWfoS5VrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SK-MEL-24	NGXucY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MW\JR\|UxRTJwN{iyNlQhKM7:TR?=	M2q3VVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
COR-L23	NFfLPYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MoDvTWM2OD1{Lke5OFY1KCEQvF2=	NG\mSIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MHH-PREB-1	NHL3NXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWLPUIg1UUN3ME2yMlgxOTZzIDFOwG0>	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-N-DZ	NGjjcGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWDJR\|UxRTJwOEG2N\|ghKM7:TR?=	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
OMC-1	NVrCN2pPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUPJR\|UxRTJwOEWwNFMhKM7:TR?=	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-MEL-2	M1LZcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHntbotKSzVyPUKuPFkzPDNiIN88US=>	MoS4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SAS	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NXnxWZhvUUN3ME2yMlk6PDF3IDFOwG0>	M2nibVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EPLC-272H	NFT4b21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnXJTWM2OD1\|LkCwNlM2KCEQvF2=	NUnxXVVGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
8505C	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1LpNWlEPTB;Mz6xNFMxOSBizszN	MkO0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EW-11	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NX3uT\|AyUUN3ME2zMlE1Ojd5IDFOwG0>	NXL3eJZxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
YKG-1	NIXVRm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYXXZ2hCUUN3ME2zMlE1PzB4IDFOwG0>	NWnOfGV3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
EC-GI-10	Mm\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MU\JR\|UxRTNwMUeyOlMhKM7:TR?=	NHPWcJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SK-LU-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3XFUWlEPTB;Mz6xPFQyQCBizszN	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
P30-OHK	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{THVGlEPTB;Mz6yNFEyPyBizszN	Mn;6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
T-24	NVXXdldCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MmD1TWM2OD1\|LkKxPFE1KCEQvF2=	M33BXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HSC-2	NYnZU25TT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYfJR\|UxRTNwMkKyN\|IhKM7:TR?=	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-MES-1	NI\vXHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXXJR\|UxRTNwMkS4NlkhKM7:TR?=	Mke0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SW48	MnzlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYnJR\|UxRTNwMkW0PFYhKM7:TR?=	NX;KS5hnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
ME-180	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3;YO2lEPTB;Mz6yOlA2OSBizszN	NF7NWHM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H2009	Mo\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MoDzTWM2OD1\|LkK5NFEhKM7:TR?=	NHLteYg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HL-60	NEj5XXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Mk[4TWM2OD1\|LkK5NVMhKM7:TR?=	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-N87	M4\GeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXvBfGhHUUN3ME2zMlMxOTd{IDFOwG0>	NY\SV2FqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
GMS-10	NYPuXIg5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NF61PXpKSzVyPUOuN\|QxQDZiIN88US=>	NFPUOnI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SCH	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnXGTWM2OD1\|LkSwPFQ1KCEQvF2=	MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
C-33-A	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV3JR\|UxRTNwNEG0NlEhKM7:TR?=	M1vDbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H1703	Mn3TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mn;RTWM2OD1\|LkSxPFEzKCEQvF2=	MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A427	M2rENGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mor5TWM2OD1\|LkS2NVI1KCEQvF2=	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MOLT-4	M2K5V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFzle\|NKSzVyPUOuOFgyQTliIN88US=>	MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1792	M{TucGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MX\JR\|UxRTNwNEm4NFIhKM7:TR?=	MlHyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1650	Ml;iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4TEbGlEPTB;Mz61O\|I6KCEQvF2=	MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
H-EMC-SS	M2LtPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVTJR\|UxRTNwNUi1OlkhKM7:TR?=	MnXhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SW982	NInGPWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVjJR\|UxRTNwNUi4NlkhKM7:TR?=	MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
DSH1	MkPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NF;5dHhKSzVyPUOuOlQyOjJiIN88US=>	M1LsSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NOS-1	NHr3VFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXLJR\|UxRTNwNkSyO\|YhKM7:TR?=	NVTMWmZxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
BT-549	NWDaVo16T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M17VdWlEPTB;Mz62O\|g2PCBizszN	M{PvRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HuCCT1	MoLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYHJR\|UxRTNwN{SxO\|chKM7:TR?=	MkHMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1755	NHfiOXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkjjTWM2OD1\|Lkm2PVcyKCEQvF2=	NFXmXG49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KYSE-450	NWTpc5UzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVPJR\|UxRTNwOU[5PVchKM7:TR?=	M{TQV\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MIA-PaCa-2	NUnxS2dlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXLJR\|UxRTNwOUeyPUAh\|ryP	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
U-266	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYfYenpTUUN3ME2zMlk4PDhzIDFOwG0>	MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
Mewo	M1nYUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEXvU25KSzVyPUSuNFY{PjFiIN88US=>	NYT1S4JkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KYSE-520	NFjFU2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2rlW2lEPTB;ND6wPVc6QSBizszN	M13XVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MN-60	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmTRTWM2OD12LkGwOVAyKCEQvF2=	Mn7UQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
Ramos-2G6-4C10	NHjQSpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{XTUGlEPTB;ND6xOlc{QSBizszN	NFLIeHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SK-MEL-1	M{O2NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmPHTWM2OD12LkG4Olk2KCEQvF2=	NEfQWW09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ABC-1	M3vN[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NX76XXk{UUN3ME20MlI{OzN\|IDFOwG0>	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
CAKI-1	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NUL0T2o4UUN3ME20MlI1PTdzIDFOwG0>	NWjvcYhJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HOS	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M33CVmlEPTB;ND6yPVE1OSBizszN	NHHlcIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SN12C	NHfoXYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUXjPZJrUUN3ME20MlM1OjR2IDFOwG0>	M{LBNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NB13	M2nT[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MlPXTWM2OD12LkO3N\|U2KCEQvF2=	MnfhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
M14	M4ftOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnP3TWM2OD12LkS4O\|kzKCEQvF2=	MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GP5d	M33oOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M13TXGlEPTB;ND61NFEzKCEQvF2=	NE\ZfZo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H720	NYXZcnppT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NH\Cbm1KSzVyPUSuOVM3OTJiIN88US=>	NFHZR5U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
D-423MG	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MlrUTWM2OD12LkWzPVI1KCEQvF2=	M3Phb\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ChaGo-K-1	NUO1VYF7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NITpfHBKSzVyPUSuOVk2PTliIN88US=>	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MEL-HO	M3jiW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M375OmlEPTB;ND62NVI3OSBizszN	MnHlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MHH-ES-1	NIrJXnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUDBZ\|lwUUN3ME20MlYzPDFzIDFOwG0>	NELDUGM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KYSE-270	MkTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1y1b2lEPTB;ND62OVEzPiBizszN	NVzQSXl7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
GI-ME-N	NGHWb25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYTJR\|UxRTRwN{GyPVEhKM7:TR?=	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HOP-92	M1n1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{\MS2lEPTB;ND64NVM4QSBizszN	MkL4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MKN1	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4\ueGlEPTB;ND64N\|kyPCBizszN	NF;wSIc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ML-2	NXjoZWNHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFO2RopKSzVyPUSuPFU3OjZiIN88US=>	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
RO82-W-1	NIrmfZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWTJR\|UxRTRwOUK5PEAh\|ryP	NVK2XYRpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
G-361	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NX;rUGlYUUN3ME21MlAyODB\|IDFOwG0>	NXezZVVxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HC-1	M2PtVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NUnQSWd6UUN3ME21MlA{OjlzIDFOwG0>	M2jYUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EW-24	M4rUVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NV7zdXBxUUN3ME21MlA1ODN6IDFOwG0>	M{TOWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HuP-T4	NWnUcGJFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MmfCTWM2OD13LkG0N\|M1KCEQvF2=	NELsRlg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
8-MG-BA	NVrab4pJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NITVXmdKSzVyPUWuN\|QzQCBizszN	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HGC-27	NWfqZZVKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHPnOJVKSzVyPUWuN\|c3QDJiIN88US=>	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
TE-12	Moq4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHLZeZpKSzVyPUWuOFE2QDViIN88US=>	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GT3TKB	NFX3UoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFLzeIJKSzVyPUWuOFQzOTJiIN88US=>	NVHDeVBTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
DOHH-2	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3\vfGlEPTB;NT60OVk5PiBizszN	MoPOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
Ca-Ski	MnT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{jLfmlEPTB;NT60OlEyPSBizszN	NGnWZ4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A172	M37ybGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFu5[YVKSzVyPUWuOVQ6OjViIN88US=>	MmrCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EGI-1	MnP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEHUb\|ZKSzVyPUWuOVg6OzhiIN88US=>	NVL2SY0zRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MZ2-MEL	NWnvOHM1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M4fa[2lEPTB;NT62NVQ5PiBizszN	NILTSpE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SW1710	Mln0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1PqOmlEPTB;NT62PVA6OSBizszN	NH;YV\|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HT-144	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnvsTWM2OD13LkeyOlg2KCEQvF2=	M3fXWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
PA-1	MlzwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWLJR\|UxRTVwOEG4PVMhKM7:TR?=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HCC1937	M4HY[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXjJR\|UxRTVwOEO5NlkhKM7:TR?=	M{XKZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SK-OV-3	NVvueJdPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkfGTWM2OD13LkmxNVIyKCEQvF2=	MkjRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
K5	MkexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlTwTWM2OD14LkC1NVchKM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NMC-G1	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUTJR\|UxRTZwMEe3PVchKM7:TR?=	MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MDA-MB-361	NG\XVmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MV3JR\|UxRTZwMEmyOlEhKM7:TR?=	M3;k[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
EKVX	NIXqNHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3\DWmlEPTB;Nj6xN\|UxOSBizszN	MnvPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ES7	NXvPTXNHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYjJR\|UxRTZwMU[xNVUhKM7:TR?=	MmDYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KS-1	M2jOU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M332WmlEPTB;Nj6xO\|k6OyBizszN	M1zTTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H661	M4r5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFXpXFVKSzVyPU[uNVgxQDFiIN88US=>	MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ES8	NF\0OFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVLJR\|UxRTZwMUiwPFIhKM7:TR?=	MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H23	NF:3b\|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NVv2bohiUUN3ME22MlIyQDF4IDFOwG0>	NYDsPZZ3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
T47D	NHnhPJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYLJdYQ{UUN3ME22MlI3PDV5IDFOwG0>	Mnu0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
A2780	M1LRR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NFjJPHNKSzVyPU[uN\|c4ODFiIN88US=>	NIPYfIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SCC-4	NInnZ3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{LyVWlEPTB;Nj60N\|U3OSBizszN	NGryR5U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
VA-ES-BJ	NYTLXJdFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlLYTWM2OD14Lkm3NFQ{KCEQvF2=	NX7MXlhrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
no-11	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV\JR\|UxRTdwMU[0NUAh\|ryP	NFTkXIQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KU-19-19	NGLSTVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnToTWM2OD15LkG2OFc3KCEQvF2=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MKN45	NELrc29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlzMTWM2OD15LkG4Olk6KCEQvF2=	M164dFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SCC-25	NXP4[GxbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIK2TopKSzVyPUeuNlM1OTRiIN88US=>	MmHSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
ETK-1	NFPKT2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGjZ[mtKSzVyPUeuNlU2OTRiIN88US=>	Ml7sQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
COR-L88	MmezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYTJR\|UxRTdwMkmzNVkhKM7:TR?=	MoHiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
8305C	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NEfWemZKSzVyPUeuN\|I1QTJiIN88US=>	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
Detroit562	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NHH6cXJKSzVyPUeuN\|I2ODZiIN88US=>	NEfMXHc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SNU-449	MmjrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{juZ2lEPTB;Nz6zO\|Y2OSBizszN	NYniSG1oRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
A704	NFO2OpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3H1d2lEPTB;Nz6zPFI4QCBizszN	NXjuOoVYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
D-502MG	M2TNO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NETibZVKSzVyPUeuN\|g1PzNiIN88US=>	M3f2e\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H2228	NYTlb\|JmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFnuc\|lKSzVyPUeuOFE1PThiIN88US=>	MljRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
CHP-212	M1:0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NWXCZoVNUUN3ME23MlUyQDl4IDFOwG0>	Mn7aQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
VMRC-RCZ	NELCOmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYTReIJSUUN3ME23MlU6ODZ4IDFOwG0>	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
RPMI-2650	M3jYRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NH7VcVJKSzVyPUeuO\|A{OTJiIN88US=>	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HCC2218	M3XCO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{T1N2lEPTB;Nz63NlI2QCBizszN	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GCT	Ml\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIW3V\|RKSzVyPUeuPFIyPzJiIN88US=>	Ml3CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SW780	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYTtcGExUUN3ME23Mlk6ODZiIN88US=>	M2LzPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KMOE-2	NFTsSWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUDsUHNEUUN3ME24MlA1ODdiIN88US=>	MoTEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KYSE-180	NVns[YZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVfz[5J5UUN3ME24MlA5PjR6IDFOwG0>	NW\KZoFIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TE-1	Mk\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Ml[2TWM2OD16LkGxNFU4KCEQvF2=	Mne1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
OAW-42	NWi2OWJST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NEnPdHNKSzVyPUiuNlU1QTZiIN88US=>	MmXXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
VM-CUB-1	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnraTWM2OD16LkK4N\|Y1KCEQvF2=	NHn5T5Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ECC10	M2XDWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEH0PHRKSzVyPUiuNlg{QTdiIN88US=>	NUDsdXdJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SW1573	NGPYbIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MU\JR\|UxRThwNES0OlUhKM7:TR?=	NUPhRVBKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H1299	MoLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4THSmlEPTB;OD61PVc4PCBizszN	NVvFSnd{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
ALL-PO	NGDmXmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NV:3XWlFUUN3ME24MlY3PTl5IDFOwG0>	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
OVCAR-5	NIPNUZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NVy5TmI{UUN3ME24Mlc4PjJ3IDFOwG0>	NFXP[ms9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-SNU-5	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{niemlEPTB;OD64N\|AxOSBizszN	NVTw[m1YRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H2342	NVv6bHZwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NF3pXmZKSzVyPUiuPFMyODFiIN88US=>	NEnaWXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
RPMI-7951	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVjxfXlbUUN3ME24Mlg1OTV5IDFOwG0>	M4mwdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
RCM-1	NFvVRYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MkH6TWM2OD17LkC4NVQ2KCEQvF2=	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
Daoy	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NXXPcVVOUUN3ME25MlEzODJ6IDFOwG0>	MmPCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HCC1395	NWG3cllyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NULBU\|JtUUN3ME25MlMxQDl4IDFOwG0>	NUK1Wo5HRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
786-0	MoXoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIHCV45KSzVyPUmuN\|YxOjZiIN88US=>	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GAMG	NIKzb29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MmjkTWM2OD17Lk[1OVM1KCEQvF2=	NI\F[JY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HCC1954	NVvRc\|dZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M37ZVWlEPTB;OT64OVg2QSBizszN	MlPXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1838	M1rq[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXzJR\|UxRTlwOUCzO\|EhKM7:TR?=	M2rXPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SW620	MnnQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MY\JR\|UxRTlwOUWzOVchKM7:TR?=	NXLhT25vRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H358	NXrJW\|FUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NF7Sbm9KSzVyPUGwMlQyQTdiIN88US=>	NGnCUJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1793	MoPxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Mkj6TWM2OD1zMD60NlQ5KCEQvF2=	NGnTbWg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1666	Mn\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlH0TWM2OD1zMD60N\|U2KCEQvF2=	MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MZ7-mel	NVjGd4NRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkTiTWM2OD1zMD60O\|U{KCEQvF2=	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MDA-MB-175-VII	NFHsTVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWnJR\|UxRTFyLk[zPVYhKM7:TR?=	MkK5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
COLO-829	NIHCbJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUjJR\|UxRTFyLkiwNFQhKM7:TR?=	M1TwRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
RVH-421	MnzuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHrXWllKSzVyPUGxMlE2OiBizszN	MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
A549	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVXJR\|UxRTFzLkK0O\|ghKM7:TR?=	M{LFT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
DJM-1	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NIHIVW9KSzVyPUGxMlM5OzNiIN88US=>	M{\JOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
IST-MEL1	M2TSVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NXTVe3B{UUN3ME2xNU44OzF7IDFOwG0>	MlPKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
BEN	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NIrz[\|dKSzVyPUGxMlc1ODJiIN88US=>	NWLFfWk6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KM12	NWTVVlNET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYrNOHYzUUN3ME2xNU46ODlzIDFOwG0>	MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HuO9	NXu0NFR2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYPIOWF5UUN3ME2xNk4xPjZ4IDFOwG0>	MojVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
U-2-OS	NI[zOZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXXJR\|UxRTF{LkC4PVMhKM7:TR?=	M1;6RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
RH-1	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnHPTWM2OD1zMj60OFczKCEQvF2=	M{nKVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H1048	MlfJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MVnJR\|UxRTF{LkW1NFYhKM7:TR?=	NX;RXo91RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
Mo-T	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXvJR\|UxRTF{LkezNFchKM7:TR?=	MlTGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KYSE-150	NIDxcnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVjJR\|UxRTF{Lke0OVUhKM7:TR?=	M13mfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
A388	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXjJR\|UxRTF{Lke3NVMhKM7:TR?=	MnjOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-SNU-1	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NEDKeYdKSzVyPUGyMlgxPDZiIN88US=>	MlHSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HEL	M{ji[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NF\1Z2lKSzVyPUGyMlgzOTJiIN88US=>	MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
UM-UC-3	Ml\LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MortTWM2OD1zMj64PFc1KCEQvF2=	NGfhTos9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
TGBC24TKB	MoP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M{LTRmlEPTB;MUOuNFI3PyBizszN	NGnmXZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SW626	NFrwNY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHracIdKSzVyPUGzMlI1QDViIN88US=>	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ES6	NHnoTZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NHe0eVFKSzVyPUGzMlI2OTJiIN88US=>	NUjxOFdkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H2029	NIOzOXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIHZTo9KSzVyPUGzMlgyODhiIN88US=>	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
RXF393	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1rDdWlEPTB;MUOuPVkzPyBizszN	MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HMV-II	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NHKyO4tKSzVyPUG0MlA4QCBizszN	MoLJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EW-22	MlvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MVPJR\|UxRTF2LkG1NFIhKM7:TR?=	MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
AsPC-1	NGDYUodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NXTWe4VHUUN3ME2xOE42PjRiIN88US=>	NWHBfZZURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
COLO-678	NYLRenBpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{X4UmlEPTB;MUSuO\|I4OSBizszN	M1vCVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
HCT-15	NGrsXZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3HzZWlEPTB;MUSuPFg2PSBizszN	MmnjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HCE-T	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnrLTWM2OD1zND64PFc1KCEQvF2=	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SF539	MljpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4PES2lEPTB;MUWuNFY1OyBizszN	NUnRR5NHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
AU565	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MkixTWM2OD1zNT6yNFk3KCEQvF2=	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
JVM-2	M1npUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NYf2S2Z3UUN3ME2xOU4zPjhzIDFOwG0>	NIixTYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
CaR-1	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Ml3sTWM2OD1zNT60OFEzKCEQvF2=	NHrDUpo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
23132-87	M{POR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVTJR\|UxRTF3Lki0PVUhKM7:TR?=	Ml35QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
A673	NYjH[mdQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MnnsTWM2OD1zNT65OlM3KCEQvF2=	MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KYSE-410	NV3YWVhDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIXhTpJKSzVyPUG2MlAzQSBizszN	NUDucmZjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
TE-9	M3XZc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MoTPTWM2OD1zNj6wOlIhKM7:TR?=	NVXWfGtORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LU-139	NHnBXFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1LwcmlEPTB;MU[uNVgzOyBizszN	MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GCIY	NH[w[4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWXJR\|UxRTF4LkG5NVYhKM7:TR?=	M4PreVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
JEG-3	MlfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIDjSppKSzVyPUG2MlI2KCEQvF2=	Mn61QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
RT-112	NIK5eoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MX7JR\|UxRTF4LkSxOFMhKM7:TR?=	MljUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
COLO-680N	M4C1Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmWxTWM2OD1zNj61NVA5KCEQvF2=	MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
LU-134-A	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYPw[lhVUUN3ME2xOk46QDl\|IDFOwG0>	M2P4V\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MFM-223	M2PFb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MX\JR\|UxRTF5LkG1N\|UhKM7:TR?=	Ml\aQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SF126	M162OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWjJR\|UxRTF5LkG3NFEhKM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H28	M4r5Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVPJR\|UxRTF5LkKwOlYhKM7:TR?=	M{DWelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
BFTC-905	NUPGXYpHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXS2cVVxUUN3ME2xO{41QDN{IDFOwG0>	NUjwboFSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SCC-9	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MlSxTWM2OD1zNz62Nlg2KCEQvF2=	M13mUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KNS-62	NVTWVVVtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MnXPTWM2OD1zNz62OlI6KCEQvF2=	M1XhPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
Hs-578-T	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4Ls[2lEPTB;MUeuPFE1QSBizszN	NWnaXVh7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
D-336MG	NVe0eZV7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXfJR\|UxRTF5LkiyPVQhKM7:TR?=	NGPCU2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H82	MkPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHjO[3dKSzVyPUG4MlAyQDNiIN88US=>	NVHXSlZXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
EFM-19	NIjmcnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M2\yb2lEPTB;MUiuNFU4PyBizszN	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
TGBC11TKB	MmXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHvTeFlKSzVyPUG4MlExOjFiIN88US=>	NXr2fY53RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HEC-1	Ml72S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M330OWlEPTB;MUiuNlkyQCBizszN	MnHBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HuP-T3	M1f5VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NIjBcFBKSzVyPUG4MlU6OjliIN88US=>	M2TWSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SF268	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYPJR\|UxRTF6Lk[3NFIhKM7:TR?=	NGHxPGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
COLO-792	NUL0enZFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHfuWIZKSzVyPUG4Mlc6QTdiIN88US=>	NIDF[mw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
HLE	M2Ds[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mlj4TWM2OD1zOD64N\|MyKCEQvF2=	NHSxbYY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A204	M4C3O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHvMUXlKSzVyPUG4MlkyPjRiIN88US=>	MmrFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
CAL-72	MonoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVjrV\|d{UUN3ME2xPU4xQDd5IDFOwG0>	M4XwT\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
U031	NH\6SYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlTxTWM2OD1zOT60PVA6KCEQvF2=	M4PoN\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
FTC-133	M4DFWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MYPJR\|UxRTF7LkmzNFQhKM7:TR?=	MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SK-MEL-28	MmHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NI\l[oVKSzVyPUKwMlM4PjFiIN88US=>	M3vXVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
KGN	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmDSTWM2OD1{MD60Olk6KCEQvF2=	MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HCC2998	NHf4ZWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXjJR\|UxRTJzLkO5NlYhKM7:TR?=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GOTO	MmnzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWPJR\|UxRTJzLkS4OUAh\|ryP	MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
AGS	MlnnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MYPJR\|UxRTJzLki0OVEhKM7:TR?=	MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
EW-13	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4\6fGlEPTB;MkKuNVAzOiBizszN	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
P12-ICHIKAWA	NX:2TVdPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFn1SIdKSzVyPUKyMlE3ODNiIN88US=>	MofFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1395	NULMSVBLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVPJR\|UxRTJ{LkK5NFchKM7:TR?=	NIjXOWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
A2058	NG\0N5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4q4fWlEPTB;MkKuOFM1KCEQvF2=	NYPyS2VMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
SH-4	NVfRZmpST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M1fhW2lEPTB;MkKuO\|A1PSBizszN	NV;MbnJ7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
DoTc2-4510	NHK0XIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUPJR\|UxRTJ\|Lk[0O\|IhKM7:TR?=	MonzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MMAC-SF	NWPHSm5ST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVToV445UUN3ME2yN{43QTFzIDFOwG0>	NGP5b5M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H510A	MlXuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEWxOJdKSzVyPUKzMlc6OzliIN88US=>	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
HDLM-2	M{LpOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Mk\5TWM2OD1{ND6xOFYhKM7:TR?=	NGCyW2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
KINGS-1	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV;JR\|UxRTJ2LkK0NkAh\|ryP	MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1648	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXfJR\|UxRTJ2LkSwNlQhKM7:TR?=	MkSxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
HCC1187	M4rtZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEXRdo1KSzVyPUK1MlAzOzViIN88US=>	M2T3PFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
BALL-1	M4TXSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1rPUWlEPTB;MkWuNlA3OiBizszN	NEi3OJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SBC-1	Mlu0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnnwTWM2OD1{NT6yPVk{KCEQvF2=	MmfLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
BFTC-909	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYjJR\|UxRTJ3LkO1OVEhKM7:TR?=	NETDdGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
MOLT-13	NInPT\|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4nmZmlEPTB;MkWuOlc1PCBizszN	MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
SW1990	NGDaR\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NUHacGlnUUN3ME2yOU46PjV3IDFOwG0>	NHzpZZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
DK-MG	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1WwTmlEPTB;Mk[uNFQ1OyBizszN	MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
TE-8	Mn\VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NIriUY1KSzVyPUK2MlA3PjhiIN88US=>	M4jFblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
Becker	NVj0T3l7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFrFZXhKSzVyPUK2MlE2PzRiIN88US=>	MmLjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
KYSE-70	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NWLjemVCUUN3ME2yOk42OzF5IDFOwG0>	M2HvNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
MKN7	Mn\VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnnvTWM2OD1{Nz63OFc6KCEQvF2=	MnfXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
D-392MG	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NH;xVmZKSzVyPUK3Mlc3QTRiIN88US=>	MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NH-12	NYrRRZVLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MoPCTWM2OD1{OD6xNlI6KCEQvF2=	MlHEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
EW-18	M1\ydmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4O1WmlEPTB;MkiuNlIyQCBizszN	NYLYTWFTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
LCLC-97TM1	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXTJR\|UxRTJ6LkK3OlIhKM7:TR?=	MlfkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1770	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUXJR\|UxRTJ6LkO1OlYhKM7:TR?=	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
BT-20	NWDuWG8xT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{\yV2lEPTB;MkiuN\|Y5PSBizszN	MoPlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
DBTRG-05MG	NH\tfI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{nnPWlEPTB;MkiuOFg{QCBizszN	NWDoUJhrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
HPAF-II	MnH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3Ky[GlEPTB;MkiuO\|c6KCEQvF2=	M2XOfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
SW837	NF32XnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlPDTWM2OD1{OT6zN\|g2KCEQvF2=	MkTiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
647-V	Ml\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Ml\jTWM2OD1{OT63NFA{KCEQvF2=	NYTkdYh2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
J82	M1rWU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmrwTWM2OD1{OT64NFE{KCEQvF2=	MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
MC116	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MkDnTWM2OD1\|MD6wO\|M{KCEQvF2=	NWizdmdXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H69	MlToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWrlTGRyUUN3ME2zNE43ODl\|IDFOwG0>	NGrtTJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NB6	MnfDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MX3JR\|UxRTNzLkO2NlkhKM7:TR?=	MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
CAL-120	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MkTTTWM2OD1\|Mj60N\|E4KCEQvF2=	MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
U-87-MG	M4raNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MnHhTWM2OD1\|Mz6wNlUyKCEQvF2=	MlnRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
NCI-H1304	NYjKUG9KT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUfJR\|UxRTN\|LkCzOVQhKM7:TR?=	NUL2Z5ZNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
YH-13	NF\2V3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXvJR\|UxRTN\|LkK1N\|UhKM7:TR?=	MkflQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
RMG-I	NUS1V2JMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXHJR\|UxRTN\|LkSyPFUhKM7:TR?=	MlHSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
LU-65	M120[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M4CyPGlEPTB;M{SuNVQxQCBizszN	MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
GB-1	MknJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NH7FcFZKSzVyPUO1MlA4OjliIN88US=>	Mnq2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
DU-4475	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NIrueWNKSzVyPUO1MlE2PTNiIN88US=>	MlPUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SBC-5	M2izT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		Ml7BTWM2OD1\|Nj61PVAzKCEQvF2=	NYHK[HZXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
OE33	NWTsRmM1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MnLBTWM2OD1\|Nz63OVc4KCEQvF2=	M1;2R\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
C8166	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mlj2TWM2OD1\|OD61NlY4KCEQvF2=	NWrSPWN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
COLO-684	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MnXETWM2OD1\|OD63OFI5KCEQvF2=	M1HtSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H1155	NUTpTYM2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MXHJR\|UxRTN7LkC0O\|EhKM7:TR?=	NHPoOIY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
ATN-1	MnrUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MoG0TWM2OD1\|OT63O\|kzKCEQvF2=	MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
KARPAS-299	NF;tRlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWfj[\|ZlUUN3ME2zPU45OzliIN88US=>	NXLSOXl4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
KNS-81-FD	NWnZWIdMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MULJR\|UxRTRyLkO2NFQhKM7:TR?=	MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
NCI-H1563	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NXH1OXVGUUN3ME20NU42ODN7IDFOwG0>	NGG2cVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NB14	M3y2T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVPJR\|UxRTR{LkeyOlMhKM7:TR?=	NFnGdJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
COLO-800	NULid2c{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWPk[4N{UUN3ME20Nk45PTF5IDFOwG0>	NXv0cGduRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
MS-1	M3joUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NW\KW\|c4UUN3ME20N{4xPDh\|IDFOwG0>	MkfxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
OVCAR-8	NXHZdFZFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHvyNWJKSzVyPUSzMlY5ODliIN88US=>	MnHEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
SK-PN-DW	M1vnSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NVjBfnJHUUN3ME20N{45Pzd4IDFOwG0>	NHvTZ4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
G-402	NIXqU2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NWXoXos3UUN3ME20N{46ODB4IDFOwG0>	M4fQOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
NCI-H2291	MlXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M3;INWlEPTB;NESuPFAyPyBizszN	NIPp[mI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
PC-3	M3S0fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NYDzOXl1UUN3ME20OU45ODJ\|IDFOwG0>	NIPVWWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1581	NV3YVIE2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3XLbmlEPTB;NEWuPVg5QSBizszN	NFjBNVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
SW1116	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3nZbmlEPTB;NEeuNFE5OiBizszN	M3PIclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
ZR-75-30	Mn34S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVP5T41TUUN3ME20O{4xOjN7IDFOwG0>	Mkn4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
OCI-AML2	M2TI[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHLXcmZKSzVyPUS3MlA6OThiIN88US=>	MonhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
MDA-MB-231	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M{K2cGlEPTB;NEeuOlI1QSBizszN	MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyPFg1PDFxJ{7TRW5ITVJ:L3G+
ES3	NXrkN\|c2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3W4NWlEPTB;NEiuN\|UzQSBizszN	NUHXSJgxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjh6NESxM{c,W0GQR1XSQE9iRg>?
NCI-H630	NX;lSHA1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Mnq5TWM2OD12OT6xO\|QzKCEQvF2=	M{HrTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFI5QDR2MT:nQnNCVkeHUkyvZV4>
OE19	NHrmSJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Mmq4TWM2OD12OT6yPVAzKCEQvF2=	NEDETXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
NCI-H1573	M1u2XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MUnJR\|UxRTR7Lk[4OlEhKM7:TR?=	NInDcII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzQDh2NEGvK\|5USU6JRWK8M4E,
EW-1	NF7lUZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYrsb\|BGUUN3ME20PU46ODh2IDFOwG0>	MorEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlg5PDRzLze+V2FPT0WUPD;hQi=>
K562	MXfDfZRwfG:6aXPpeJkh[XO\|YYm=	M4\TPVczKGi{cx?=	M1XORWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGs2PjJiY3XscJMh[XO\|ZYPz[YQh[XNiY3XscEB3cWGkaXzpeJkh[W[2ZYKgO\|IhcHK\|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvODB2MzFOwG0v	M2PnUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4OEG0PFkxLz5{NkixOFg6ODxxYU6=
HEK293	M3;PWWZ2dmO2aX;uJIF{e2G7	NIjXWoQyKGi{	NGSzZW5KdmirYnn0bY9vKG:oIHj1cYFvKG[3bHygcIVv\3SqIGDLUXlVOSCneIDy[ZN{\WRiaX6gTGVMOjl\|IHPlcIx{KHW\|aX7nJGVHWyBqMkS3JJRwKDJ3OTDy[ZNq\HWnczmgZZMhe3Wkc4TyZZRmKGGodHXyJFEhcHJiYomg[ox2d3Knc3PlcoNmKHCxbHHybZpifGmxbjDpcY12dm:jc3H5MEBMcSB;IECuNFEzPyEQvF2u	MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl2MUG5N{c,Ojl7NEGxPVM9N2F-
fibroblast cells	NX7lZnlWSW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		Ml\JRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDTdoMufHKjboPmc5Ju\WRicnH0NkBncWK{b3LsZZN1KGOnbHzzMEBKSzVyIE2gNE4yKM7:TT6=	MlXvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTdzOEGxO\|AoRjF5MUixNVcxRC:jPh?=
fibroblast cells	MkTCSpVv[3Srb36gZZN{[Xl?		NGD5N4ZKdmirYnn0bY9vKG:oIHj1cYFvKGOVcnOtenNz[yCodYPpc44heHKxdHXpckBmgHC{ZYPz[YQhcW5icnH0JIZq[nKxYnzhd5Qh[2WubIOgZpkhTUyLU1GsJGlEPTBiPTCwMlEh\|ryPLh?=	M2TNXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5OUC1OVg3Lz5zN{mwOVU5PjxxYU6=
Ba/F3	NGHKXnNHfW6ldHnvckBie3OjeR?=	Mnf3OFghcHK\|	MlzuTY5pcWKrdHnvckBw\iCEQ2KtRWJNOSCHM{W1S{BufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBDS1JvQVLMNU1u\WSrYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOTJ6IN88UU4>	Mn\3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzM{e5PFEoRjNyMUO3PVgyRC:jPh?=
HEK293	NHu2[5NHfW6ldHnvckBie3OjeR?=	NGnGVoIyKGi{	M3v4UGlvcGmkaYTpc44hd2ZiaIXtZY4h\nWubDDs[Y5ofGhiUFvNXXQyKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMhfXOrbnegSWZUKCh{NEegeI8hOjV7IILld4llfWW\|KTDhd{B{fWK\|dILheIUh[W[2ZYKgNUBpeiCkeTDmcJVwemW\|Y3XuZ4UheG:uYYLpfoF1cW:wIHntcZVvd2G\|YYmsJGlEPTBiPTCwMlE{OyEQvF2u	M{PXc\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7OUSxNVk{Lz5{OUm0NVE6OzxxYU6=
Ba/F3	NHn5XYFHfW6ldHnvckBie3OjeR?=	MoH4OFghcHK\|	NVLrV4xKUW6qaXLpeIlwdiCxZjDCR3IuSUKOMTDFOFU6UyCvdYThcpQhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5ibX;1d4UhSmFxRkOgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCEQ2KtRWJNOS2vZXTpZZRm\CClZXzsJJBzd2yrZnXyZZRqd25iYX\0[ZIhPDhiaILzJIJ6KEK{aYTlUIlocHRibIXjbYZmemG\|ZTDhd5NigSxiR1m1NEA:KDBwMUSg{txONg>?	NFXl[4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
Ba/F3	M1jJSWZ2dmO2aX;uJIF{e2G7	MYi0PEBpenN?	Mn74TY5pcWKrdHnvckBw\iCEQ2KtRWJNOSCJMkWwTEBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBDS1JvQVLMNU1u\WSrYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOTR4IN88UU4>	MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF\|N{m4NUc,OzBzM{e5PFE9N2F-
Ba/F3	NIjUN2JHfW6ldHnvckBie3OjeR?=		NIfCcHhKdmirYnn0bY9vKG:oIF7QUU9CVEtiTEK1OnQhdXW2YX70JItqdmG\|ZTDhZ5Rqfmm2eTDpckBD[UZ\|IHPlcIx{KGK7IILh[Ilw\W68eX3heIlkKGG\|c3H5MEBKSzVyIE2gNE4yPSEQvF2u	NYnHenJLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[5O\|A1ODBpPkG2PVcxPDByPD;hQi=>
Ba/F3	MWXGeY5kfGmxbjDhd5NigQ>?	MlrpOFghcHK\|	NF\o[YNKdmirYnn0bY9vKG:oIFLDVk1CSkxzIGmyOVNJKG23dHHueEApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCvb4Xz[UBD[S:IMzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEKFUj3BRmwyNW2nZHnheIVlKGOnbHygdJJwdGmoZYLheIlwdiCjZoTldkA1QCCqcoOgZpkhSnKrdHXMbYdpfCCudXPp[oVz[XOnIHHzd4F6NCCJSUWwJF0hOC5zN{eg{txONg>?	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF\|N{m4NUc,OzBzM{e5PFE9N2F-
Ba/F3	NITDNGdHfW6ldHnvckBie3OjeR?=	NILRVYs1QCCqcoO=	MnO0TY5pcWKrdHnvckBw\iCEQ2KtRWJNOSCIM{W5WkBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBDS1JvQVLMNU1u\WSrYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOTl3IN88UU4>	MoXEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzM{e5PFEoRjNyMUO3PVgyRC:jPh?=
Ba/F3	NV\WfHF7SW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=		M4TKO2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcZVzcW6nIFLhSlMh[2WubIOg[ZhxemW\|c3nu[{BPWE1xQVzLJGwzPT[WIH31eIFvfCCkeTDbN2hefGi7bXnkbY5mKHWydHHr[UBie3OjeTygTWM2OCB;IECuNkDPxE1w	NHfSd2o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNkm3NFQxOCd-MU[5O\|A1ODB:L3G+
Ba/F3	NIn0XpFHfW6ldHnvckBie3OjeR?=		MnWzTY5pcWKrdHnvckBw\iCQUF2vRWxMKEx{NU\UJI12fGGwdDDheZRweGixc4Doc5J6dGG2aX;uJIFkfGm4aYT5JIlvKEKjRkOgZ4VtdHNiYomgZY51cXCqb4PwbI91gXKxc3nu[UBqdW23bn;icI91fGmwZzDhd5NigSxiSVO1NEA:KDBwMjFOwG0v	M16xPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4OUewOFAxLz5zNkm3NFQxODxxYU6=
Ba/F3	MX\GeY5kfGmxbjDhd5NigQ>?	NI\ybXU1QCCqcoO=	NWfkVZZOUW6qaXLpeIlwdiCxZjD3bYxlKHS7cHWgRmNTNUGETEGgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvOjB2IN88UU4>	MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF\|N{m4NUc,OzBzM{e5PFE9N2F-
Ba/F3	NFHZ[nBHfW6ldHnvckBie3OjeR?=	NWfwSIZCPDhiaILz	NUX3ZnRQUW6qaXLpeIlwdiCxZjDCR3IuSUKOMTDRNlUzUCCvdYThcpQhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5ibX;1d4UhSmFxRkOgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCEQ2KtRWJNOS2vZXTpZZRm\CClZXzsJJBzd2yrZnXyZZRqd25iYX\0[ZIhPDhiaILzJIJ6KEK{aYTlUIlocHRibIXjbYZmemG\|ZTDhd5NigSxiR1m1NEA:KDBwMkSzJO69VS5?	NIDGXJI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
Ba/F3	MkPtSpVv[3Srb36gZZN{[Xl?	NUPvfVI5PDhiaILz	NVr5UnBQUW6qaXLpeIlwdiCxZjDCR3IuSUKOMTDFNlU2XiCvdYThcpQhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5ibX;1d4UhSmFxRkOgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCEQ2KtRWJNOS2vZXTpZZRm\CClZXzsJJBzd2yrZnXyZZRqd25iYX\0[ZIhPDhiaILzJIJ6KEK{aYTlUIlocHRibIXjbYZmemG\|ZTDhd5NigSxiR1m1NEA:KDBwMke4JO69VS5?	NG\QTXo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
Ba/F3	MWnGeY5kfGmxbjDhd5NigQ>?	MYm0PEBpenN?	NFrubGFKdmirYnn0bY9vKG:oIFLDVk1CSkxzIFWyOVVMKG23dHHueEApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCvb4Xz[UBD[S:IMzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEKFUj3BRmwyNW2nZHnheIVlKGOnbHygdJJwdGmoZYLheIlwdiCjZoTldkA1QCCqcoOgZpkhSnKrdHXMbYdpfCCudXPp[oVz[XOnIHHzd4F6NCCJSUWwJF0hOC5\|NU[g{txONg>?	M4fEXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMUO3PVgyLz5\|MEGzO\|k5OTxxYU6=
fibroblast cells	M4m5TGZ2dmO2aX;uJIF{e2G7		MWTJcohq[mm2b4L5JINwdmOnboTyZZRqd25iYXfhbY5{fCCDYnygeJJidnOob4Lt[YQhemG2IH\pZpJw[myjc4SgZ4VtdHNuIFnDOVAhRSByLkS5JO69VS5?	NYHBVXpRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[xOlE6QTVpPkG2NVYyQTl3PD;hQi=>
Ba/F3	M{f1b2Z2dmO2aX;uJIF{e2G7	M371PFQ5KGi{cx?=	MlXTTY5pcWKrdHnvckBw\iCEQ2KtRWJNOSCWM{G1TUBufXSjboSgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO\|ZXSgbY4hdW:3c3WgRoEwTjNiY3XscJMh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgOFghcHK\|IHL5JGJzcXSnTHnnbJQhdHWlaX\ldoF{\SCjc4PhfUwhT0l3MDC9JFAvPjR{IN88UU4>	NH\aUIo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9\|MEGzO\|k5OSd-M{CxN\|c6QDF:L3G+
Ba/F3	MXHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?		NHf0TFhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JI12emmwZTDCZWY{KGOnbHzzJIV5eHKnc4Ppcochf2muZDD0fZBmKE6STT;BUGsh[nliW{PIYZRpgW2rZHnu[UB2eHSja3WgZZN{[XluIFnDOVAhRSBzIN88UU4>	M3LsPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4OUewOFAxLz5zNkm3NFQxODxxYU6=
HepG2	NGSwO3JCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	NYG0O3V7PDhiaILz	MUXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEincFeyJINmdGy\|IHHmeIVzKDR6IHjyd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKGG\|c3H5MEBIUTVyIE2gNU4yPSEQvF2u	M12ybVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi1O\|E2Lz5zOES4OVcyPTxxYU6=
HT29	NIT4[oZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?=	M1jUXFQ5KGi{cx?=	NY\rV4NTSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWFI6KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwJF0hOS5zNzFOwG0v	M2TqNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi1O\|E2Lz5zOES4OVcyPTxxYU6=
BA/F3	MnHNR5l1d3SxeHnjbZR6KGG\|c3H5	M33qUFczKGi{cx?=	NWfkbHNKS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDCR3IuSUKOIGSzNVVKKG23dHHueEBi\nSncjC3NkBpenNiYomgUXRVKGG\|c3H5MEBKSzVyIE2gN{4zKM7:TT6=	NUHyRXQ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[4NVQ5QTBpPkK2PFE1QDlyPD;hQi=>
HeLa	M17xb2Z2dmO2aX;uJIF{e2G7	NYO0UlF7PC53IHjydy=>	NXnRUlRjUW6qaXLpeIlwdiCxZjDFZo9t[X[rcoXzJIdtgWOxcILveIVqdi:vYYTybZgheHKxdHXpckBXWDRyIHXueJJ6KGmwIHj1cYFvKEinTHGgZ4VtdHNiYX\0[ZIhPC53IHjyd{Bj\XSjLXzhZ5RidWG\|ZTDy[ZBwenSncjDhd5NigSxiSVO1NEA:KDNwOEWg{txONg>?	M4rjUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NkK0N\|g4Lz5{OU[yOFM5PzxxYU6=
HT29	MUXBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?	MmXNOFghcHK\|	NXuxVlY{SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWFI6KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCLQ{WwJF0hOy56NzFOwG0v	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDR6NUexOUc,OTh2OEW3NVU9N2F-
HepG2	NXyyZ\|UySW62aYDyc4xq\mW{YYTpeoUh[XO\|YYm=	M2rtbFQ5KGi{cx?=	MXnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEincFeyJINmdGy\|IHHmeIVzKDR6IHjyd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKGG\|c3H5MEBKSzVyIE2gN{46OSEQvF2u	M1H0U\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi1O\|E2Lz5zOES4OVcyPTxxYU6=
HT29	MVLBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?	MYS0PEBpenN?	MorLRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCKVEK5JINmdGy\|IHHmeIVzKDR6IHjyd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKGG\|c3H5MEBVT0liPTC2MlUh\|ryPLh?=	M{TkVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi1O\|E2Lz5zOES4OVcyPTxxYU6=
HepG2	MXHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>?	NH7JSo01QCCqcoO=	MVrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEincFeyJINmdGy\|IHHmeIVzKDR6IHjyd{BjgSC\|dXzmc5Jpd2SjbXnu[UBDKGG\|c3H5MEBVT0liPTC3MlY3KM7:TT6=	M{nQSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEi1O\|E2Lz5zOES4OVcyPTxxYU6=
Ba/F3	NXPaTotZS2WubDDk[YF1cCCjc4PhfS=>		Moi1TY5lfWO2aX;uJI9nKGOnbHyg[IVifGhib3[gcZVzcW6nIFLhSlMh[2WubIOg[ZhxemW\|c3nu[{BPWE1xQVzLJGwzPT[WIH31eIFvfCCkeTD0dplx[W5iYnz1[UBmgGOudYPpc44h[XO\|YYm=	M3jMS\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF4OUewOFAxLz5zNkm3NFQxODxxYU6=
A673	NFLDbmFyUFSVIHHzd4F6		NHS3RnJyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQU[3N{Bk\Wyucx?=	NHq3WoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
DAOY	NEK4clByUFSVIHHzd4F6		Mn:xdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[\|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN?	NXvveo04RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
Saos-2	NECwVFRyUFSVIHHzd4F6		NIH1OJVyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU3Hvd{0zKGOnbHzz	NFXlb2Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
RD	NWnOXGNXeUiWUzDhd5NigQ>?		NGfUZoNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiUlSgZ4VtdHN?	NVvvfJVtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N\|UyOzlpPkK5OFM2OTN7PD;hQi=>
OHS-50	NEjs[lNyUFSVIHHzd4F6		MYTxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW\|IH\vdkBlenWpIILldJVzeG:\|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhV0iVLUWwJINmdGy\|	NFrte4s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N\|UyOzl:L3G+
SK-N-MC	NF\vdnhyUFSVIHHzd4F6		NWXmd3pJeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC\|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM>	MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR\|NUGzPUc,Ojl2M{WxN\|k9N2F-

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	p-Src / Src / p-c-Abl / c-Abl / p-S6 / S6 / p-ERK / ERK / p-STAT3 / STAT3; PubMed: 27903968 Oncotarget IMR-32, NB-19, SH-SY5Y, and SK-N-AS cells were treated with indicated concentrations of bosutinib for 0-8 hrs and the cells were lysed and subjected to immunoblotting with the indicated antibodies. β-Actin was used as a loading control in all experiments. p-FAK / FAK / p-Pyk2 / p-p130Cas / p-AKT; PubMed: 18483306 Mol Cancer Ther Western blot analysis of MDA-MB-468 whole cell extracts. Cells were treated with SKI-606 or 0.01% DMSO at the indicated concentrations for times up to 3 h prior to extraction. Immunoblots were probed as indicated with antibodies to phospho-Src (pY419), phospho-FAK (pYpY576/577 or pY925), phospho-Pyk2 (pY580), phospho-p130Cas (pY410), phospho-Stat3 (pY705), phospho-Akt (pS473), phospho-MAPK p44/42, beta-catenin, or PARP. Blots were re-probed with total anti-Src, anti-FAK, or anti-Stat3 antibodies, as indicated. p-ABL / ABL ; PubMed: 28199182 eLife Cells were transfected with human wild-type ABL, and p190 and p210 variants of BCR-ABL, treated with inhibitors for 24 hr and analyzed for activating phosphorylation (p) by immunoblot. Actin and total levels of expressed kinases serve as loading controls. Cells transfected with empty plasmid serve as transfection control.	27903968 18483306 28199182
Immunofluorescence	p-FAK / p-STAT3 / beta-catenin; PubMed: 18483306 Mol Cancer Ther MDA-MB-231 cells were treated with 0.01% DMSO or 1 µM SKI-606 for 48 h then fixed, probed with antibodies to phospho-FAK (pY576/pY577), FAK, phospho-Stat3 (pY705) or beta-catenin as indicated, and stained with DAPI. Images were captured under fluorescence at 40x magnification.	18483306
Growth inhibition assay	Cell viability; PubMed: 24812339 Bioinformatics Proliferation curves for bosutinib, gefitinib and sorafenib in (A) H1650 and (B) H1975. IC50; PubMed: 27903968 Oncotarget Six NB cell lines, IMR-32, NGP, NB-19, CHLA-255, SH-SY5Y, and SK-N-AS, were treated with increasing concentrations of bosutinib for 48 hrs. Cell viability was measured by performing the Cell Counting Kit-8 (CCK-8) assay.	24812339 27903968

In vivo

Bosutinib (60 mg/kg/day) is active against Src-transformed fibroblasts xenografts and HT29 xenografts in nude mice with T/C of 18% and 30%, respectively. ^[1] Oral administration of Bosutinib for 5 days significantly suppresses K562 tumor growth in mice in a dose-dependent manner, with the large tumors eradicated at dose of 100 mg/kg and tumor free at 150 mg/kg without overt toxicity. ^[2] As being inactive against Colo205 xenografts in nude mice at 50 mg/kg twice daily, Bosutinib dosing at 75 mg/kg twice daily is necessary against Colo205 xenografts, and increasing the dose of Bosutinib has no additional benefit, in contrast to the significant dose-dependent ability against HT29 xenografts. ^[4]

Protocol

Kinase Assay: ^[1]	- Collapse The Src and Abl kinase assays: The Src kinase activity is measured in an ELISA format. Src (3 units/reaction), reaction buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl₂, 0.1 mM EGTA, 0.5 mM Na₃VO₄) and cdc2 substrate peptide are added to various concentration of Bosutinib and incubated at 30 °C for 10 minutes. The reaction is started by the addition of ATP to a final concentration of 100 μM, incubated at 30 °C for 1 hour and stopped by addition of EDTA. Instructions from the manufacturer are followed for subsequent steps. The Abl kinase assay is performed in a DELFIA solid phase europium-based detection assay format. Biotinylated peptide (2 μM) is bound to streptavidin-coated microtitration plates for 1.5 hours in 1 mg/mL ovalbumin in PBS. The plates are washed for 1 hour with PBS/0.1% Tween 80, followed by a PBS wash. The kinase reaction is incubated for 1 hour at 30°C. Abl kinase (10 units) is mixed with 50 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, 80 μM EGTA, 100 μM ATP, 0.5 mM Na₃VO₄, 1% DMSO, 1 mM HEPES (pH 7.0), 200 μg/mL ovalbumin and various concentration of Bosutinib. The reaction is stopped with EDTA at a final concentration of 50 mM. The reaction is monitored with Eu-labeled phosphotyrosine antibody and DELFIA enhancement solution.
Cell Research: ^[2]	- Collapse Cell lines: Abl-MLV, Rat 2, KU812, K562, and MEG-01 cells Concentrations: Dissolved in DMSO, final concentrations ~1 μM Incubation Time: 72 hours Method: Cells are exposed to various concentrations of Bosutinib for 72 hours. Anchorage-independent proliferation of Abl-MLV-transformed fibroblasts is measured in 96-well ultra-low binding plates treated with Sigmacote to block residual cell attachment. Cell proliferation is measured with MTS or Cell-Glo. For the determination of cell cycle or cell death, cells are prepared for FACS analysis in the CycleTest Plus DNA reagent kit and analyzed on a fluorescence-activated cell sorter flow cytometer. (Only for Reference)
Animal Research: ^[2]	- Collapse Animal Models: Nude female mice injected with K562 cells Dosages: ~150 mg/kg/day Administration: Oral gavage (Only for Reference)

References

- Collapse

Solubility (25°C)

In vitro	DMSO	100 mg/mL (188.51 mM)
	Ethanol	2 mg/mL (3.77 mM)
	Water	Insoluble
In vivo	Add solvents to the product individually and in order(Data is from Selleck tests instead of citations): 2% DMSO+30% PEG 300+5% Tween 80+ddH2O For best results, use promptly after mixing.	10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download Bosutinib (SKI-606) SDF

Molecular Weight	530.45
Formula	C₂₆H₂₉Cl₂N₅O₃
CAS No.	380843-75-4
Storage	3 years-20°C powder 2 years-80°C in solvent
Synonyms	N/A
Smiles	CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage

mg/kg

Average weight of animals

Dosing volume per animal

Number of animals

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO+ % + % Tween 80+ % ddH₂O

Calculate Reset

Calculation results:

Working concentration： mg/ml；

Method for preparing DMSO master liquid: ： mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL， Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation：Take μL DMSO master liquid, next addμL PEG300， mix and clarify, next addμL Tween 80，mix and clarify, next add μL ddH₂O，mix and clarify.

Note：1.Please make sure the liquid is clear before adding the next solvent.
2.Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2021-05-17)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT04258943	Recruiting	Drug: Bosutinib	Philadelphia Chromosome Positive CML\|Accelerated Phase Chronic Myelogenous Leukemia\|Blastic Phase Chronic Myelogenous Leukemia\|Chronic Phase Chronic Myelogenous Leukemia	Children''s Oncology Group\|Erasmus MC\|Dutch Childhood Oncology Group\|Innovative Therapies for Children with Cancer\|Pfizer	April 6 2020	Phase 1\|Phase 2
NCT03888222	Active not recruiting	Drug: Placebo Oral Tablet\|Drug: Bosutinib Oral Tablet	Dementia With Lewy Bodies	Georgetown University\|Alzheimer''s Association	April 23 2019	Phase 2
NCT03854903	Recruiting	Drug: Palbociclib\|Drug: Bosutinib\|Drug: Fulvestrant	Metastatic Breast Cancer\|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast\|Hormone Receptor Positive Breast Cancer	Georgetown University\|Pfizer	April 1 2019	Phase 1
NCT03831776	Recruiting	Drug: Bosutinib\|Drug: Ropeginterferon	Chronic Myeloid Leukemia	St. Olavs Hospital\|Haukeland University Hospital\|Oslo University Hospital\|University Hospital of North Norway\|Helse Stavanger HF\|Henri Mondor University Hospital\|Hôpital René Huguenin\|Hôpital Mignot Versailles Paris\|Uppsala University Hospital\|Odense University Hospital	March 25 2019	Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
Can I give S1014 Bosutinib to mice by oral gavage? If so, how to dissolve the drug?
Answer:
For oral gavage, S1014 Bosutinib can be dissolved in 5% Tween 80+0.5% CMC Na at 30 mg/ml as a suspension.

Src Signaling Pathway Map

Src Inhibitors with Unique Features

Most Potent Src Inhibitor

Dasatinib : Src, IC50=0.8 nM.
FDA-approved Src Inhibitor

Dasatinib : Approved by FDA for CML and Ph+ ALL.
Newest Src Inhibitor

PP1 : Potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
Classic Src Inhibitor

KX2-391 : The first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

Related Src Products

Dasatinib Monohydrate ^New

Dasatinib Monohydrate (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM, respectively.
SU6656 ^New

SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
PX-478 2HCl ^New

PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. PX-478 2HCl induces apoptosis and has anti-tumor activity. Phase 1.
Saracatinib (AZD0530)

Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM in cell-free assays, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q). Saracatinib induces autophagy. Phase 2/3.

Features:The 1st Src inhibitor to show inhibition of the Src pathway in human tumor tissue.
Dasatinib (BMS-354825)

Dasatinib (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM in cell-free assays, respectively. Dasatinib induces autophagy and apoptosis with anti-tumor activity.
KX2-391 (Tirbanibulin)

KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
PP1

PP1 (AGL 1872, EI 275) is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
PP2

PP2 (AG 1879, AGL 1879), a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM in cell-free assays, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA.
WH-4-023

WH-4-023 (KIN001-112, KIN112, Dual LCK/SRC inhibitor) is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.
Ibrutinib (PCI-32765)

Ibrutinib (PCI-32765) is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM in cell-free assays, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc. Ibrutinib is applicable as a Btk ligand in the synthesis of a series of PROTACs including P13I.

Choose Your Country or Region

By Signaling Pathways

By product type

Bosutinib (SKI-606)